Nuvalent Total Current Assets from 2010 to 2024

NUVL Stock  USD 96.76  0.46  0.48%   
Nuvalent Total Current Assets yearly trend continues to be quite stable with very little volatility. Total Current Assets may rise above about 762.8 M this year. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2010-12-31
Previous Quarter
726.5 M
Current Value
762.8 M
Quarterly Volatility
276.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nuvalent financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvalent's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.5 K, Interest Expense of 24.4 M or Selling General Administrative of 38.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.42. Nuvalent financial statements analysis is a perfect complement when working with Nuvalent Valuation or Volatility modules.
  
Check out the analysis of Nuvalent Correlation against competitors.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.

Latest Nuvalent's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Nuvalent over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Nuvalent's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nuvalent's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Nuvalent Total Current Assets Regression Statistics

Arithmetic Mean153,448,360
Geometric Mean13,845,724
Coefficient Of Variation180.13
Mean Deviation219,216,795
Median3,316,000
Standard Deviation276,410,010
Sample Variance76402.5T
Range759.5M
R-Value0.76
Mean Square Error34410.6T
R-Squared0.58
Significance0.0009
Slope47,143,285
Total Sum of Squares1069634.9T

Nuvalent Total Current Assets History

2024762.8 M
2023726.5 M
2022478 M
2021290.6 M
202010.6 M

About Nuvalent Financial Statements

Nuvalent investors utilize fundamental indicators, such as Total Current Assets, to predict how Nuvalent Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets726.5 M762.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nuvalent is a strong investment it is important to analyze Nuvalent's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuvalent's future performance. For an informed investment choice regarding Nuvalent Stock, refer to the following important reports:
Check out the analysis of Nuvalent Correlation against competitors.
For more information on how to buy Nuvalent Stock please use our How to buy in Nuvalent Stock guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvalent. If investors know Nuvalent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvalent listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.49)
Return On Assets
(0.19)
Return On Equity
(0.30)
The market value of Nuvalent is measured differently than its book value, which is the value of Nuvalent that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvalent's value that differs from its market value or its book value, called intrinsic value, which is Nuvalent's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvalent's market value can be influenced by many factors that don't directly affect Nuvalent's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvalent's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvalent is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvalent's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.